Scientia Ventures
Venture capitalNew York · Series A–Series B · 13 people tracked
Also known as VANTAGE CONSULTING GROUP INC
Investment thesis
Scientia Ventures targets novel and unique innovations with breakthrough potential, concentrating on the science and technology advances required to achieve radical change. As a global firm, it aims to pair the expertise and network of its team with visionary entrepreneurs, using its experience, deep network, and flexible approach as a proprietary edge. The team works to identify optimal strategic approaches and solutions for its portfolio companies, and its investors and general partners take a long-term view of venture success.
Source: firm website, verified Aug 25, 2026.
Team · 13 people
from the firm's website & public directories
What they invest in
from 20 of 26 portfolio companiesBiotech ×13Healthtech ×13Medical Devices ×4SaaS ×4Fintech ×3AgTech ×2AI & Machine Learning ×2Digital Health ×2
HQs:United States×11
Investments · 26 tracked
founders shown can be your intro pathBy year:2016 · 12015 · 12014 · 35 dated
ADC Therapeutics is a biopharmaceutical company that develops antibody drug conjugates and other therapies focused on hematology and oncology.
BiotechHealthtechMedical Devices
Ameet Mallik(Chief Executive Officer)Jose Carmona(Chief Financial Officer)Mohamed Zaki(Chief Medical Officer)Kristen Harrington-Smith(Chief Commercial Officer)David Ege(Chief Technical Officer)Peter Graham(Chief Legal Officer)
Co-investorsETCapital
Cibus develops crops using a proprietary gene-editing technology that reproduces nature's own genetic blueprints to add specific traits, such as resistance to heat, pests, fungus, and weeds.
AgTechBiotechClimate TechSan Diego, US
Peter Beetham(Chief Executive Officer)Rory Riggs(Chairman of the Board)Keith Walker, Ph.D.(President)LaDon Johnson(Executive Officer)
BoardAlain Pompidou(Director)
Board seatMark FinnRory Riggs· per SEC Form D
eReceivables provides healthcare claims recovery and underpayment forensics through its Claim Axis platform, which automates payer appeals, timed escalations, and resolution for denied, aged, and small-balance claims.
FintechHealthtechSaaSHollywood, US
William Whitaker(Chief Operating Officer)Gil Perry(Executive Officer)Steven Griffin(President)
BoardBarbara Rohan(Director)
Board seatRory RiggsJonathan Finn· per SEC Form D
BiotechMarkham
Leslie Auld(Executive Officer, Director)James Howard-Tripp(Executive Officer, Director)Heiner Dreismann(Director)Garth MacRae(Director)Floyd C. Dent III(Director)
Board seatRory RiggsHarry Glorikian· per SEC Form D · $7.4M raise · filed Feb 2022
1910 develops an AI platform that integrates multimodal data, frontier AI models, and high-throughput lab automation to accelerate drug discovery and development for pharmaceutical companies.
AI & Machine LearningBiotechDeep TechHealthtechBoston, US
Co-investorsY CombinatorFoundersX VenturesPlayground Global
Develops proprietary Antibody Drug Conjugates for treating solid and hematological cancers.
Co-investorsEshelman Ventures, LLC
ConnectureDRX provides a SaaS platform for Medicare shopping, quoting, enrollment, and member retention, including plan comparison tools, drug cost savings solutions, analytics, and APIs.
HealthtechInsurTechSaaSBrookfield, US
Lea DeVillers(Executive Officer)David A. Sockel(Executive Officer)Jeffrey A. Surges(Executive Officer, Director)Mark E. Granville(Executive Officer)James P. Purko(Executive Officer)Robert Douglas Schneider(Executive Officer)
Co-investorsAtlanta Technology AngelsChrysalis Ventures
Kyntra Bio (formerly FibroGen) is a clinical-stage biopharmaceutical company developing therapies for oncology and rare diseases, including serious and life-threatening conditions.
BiotechHealthtechSan Francisco, US
Frank H. Valone(Executive Officer)Thomas F. Kearns(Director)K. Peony Yu(Executive Officer)Jorma Routti(Director)Miguel Madero(Director)Rory B. Riggs(Director)
Co-investorsAvalon BioVenturesRidgeback CapitalMaverick Ventures
X-vax Legend sells "Nagapetir" branded decorative stickers with various designs for use on motorcycles, cars, laptops, helmets, and community or brand promotion.
E-commerce
Co-investorsAdjuvant Capital
Humanity offers an enterprise employee wellness platform that uses biological age monitoring to help teams improve health and productivity.
Digital HealthHealthtechHR TechLongevityWellness & Fitness
Peter Ward(Founder)in
Co-investorsOne Way VenturesAndreessen HorowitzJump CryptoPantera CapitalSuperAngel
Intelinair provides aerial imagery and agronomic analytics through its AGMRI platform, delivering in-season alerts and postseason reporting on crop health, weeds, nitrogen deficiency, stand assessment, and yield loss.
AgTechAI & Machine LearningSaaSSan Jose, US
Naira Hovakimyan(Chief Scientific Officer and Secretary)inAlfred Eisaian(President and Chief Executive Officer)Al Eisaian(Founder)in
Co-investorsGranatus VenturesHyde Park Venture Partners
Intra-Cellular Therapies develops treatments for neuropsychiatric, neurologic, and related disorders, including its product CAPLYTA.
BiotechHealthtech
PayEase operates a payment platform offering internet payments, mobile payments, cross-border payments, foreign card acquiring, and foreign-trade collections for businesses.
FintechSaaS
Pharmaron is a life science contract research and manufacturing service provider covering drug discovery, preclinical and clinical development, and commercialization.
BiotechHealthtechMedical Devices
Co-investorsAisling CapitalDCM VenturesDCMLegend Capital
Rose Pharma is a pharmaceutical company developing ROSE-010, an on-demand GLP-1 therapy aimed at treating acute pain from irritable bowel syndrome (IBS) as well as obesity and appetite control.
BiotechHealthtech
Royalty Pharma is a buyer of biopharmaceutical royalties and a funder of life sciences innovation, providing tailored funding solutions and partnerships to biopharma companies.
BiotechFintech
Sprout Pharmaceuticals is a pharmaceutical company focused on women's sexual health, known for developing Addyi (flibanserin), the first FDA-approved treatment for low libido in women.
BiotechFemTechHealthtechRaleigh, US
Robert S. Whitehead(Director, Executive Director)Cindy Eckert(Founder)Cynthia Whitehead(Chief Commercial Officer)Anne Tomalin(Vice President, Global Regulatory Affairs)Matthew Petzold(Chief Financial Officer and Treasurer)Douglas Eckert(Director, Secretary)
VERIGRAFT develops technology that modifies donated tissue so it resembles a patient's own tissue, aiming to eliminate immune rejection in transplantation and reduce the need for lifelong immunosuppressants.
BiotechHealthtechMedical Devices
Petter Björquist(PhD, Chief Executive Officer)
Co-investorsCapital Cell
Warm Health Technology builds mobile health (mHealth) platforms for people living with chronic conditions and their healthcare providers, supporting collaborative management of health and well-being.
Digital HealthHealthtech
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.
Exits · 1
IPOs and acquisitions across the tracked portfolioADC Therapeutics SANYSE: ADCT
Portfolio news
latest coverage across their companiesPharmaron · prnewswire.com · Jan 27, 2026
IntelinAir | AGMRI · intelinair.com · Dec 3, 2025
1910 · tobaccoreporter.com · Sep 10, 2025
Frequently asked questions
- How many investments has Scientia Ventures made?
- Scientia Ventures has 25 tracked investments.
- What stage does Scientia Ventures invest at?
- Scientia Ventures invests at the Series A, Series B stages.
- What sectors does Scientia Ventures focus on?
- Scientia Ventures focuses on Biotech, Deep Tech, Healthtech, Medical Devices.
- Where is Scientia Ventures located?
- Scientia Ventures is headquartered in New York, US.
- Who does Scientia Ventures co-invest with?
- Scientia Ventures most often shares deals with DCM Ventures, Granatus Ventures, One Way Ventures, among 14 tracked co-investors.
Similar investors
ACT Venture Capital is an independent Irish venture capital firm that invests €1 million to €15 million in growth-stage private companies, with capacity for larger commitments through syndicated rounds.
Amadeus Capital Partners is a technology investment firm that backs founders building complex, science-led and deep tech businesses, supporting them over the long term as they scale internationally.
.jpeg){kind=logo}
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.
Capricorn Partners is a Belgium-based, partner-owned independent management company for alternative investment funds, investing in innovative companies across digital, health and clean technologies with an ESG focus.
DCVC (Data Collective) is a deep tech venture capital firm that backs entrepreneurs using computational approaches to solve large-scale real-world problems across many industries.